Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer [Phase 2]
Phase 2 pharmacodynamic trial update in newly diagnosed operable breast cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: Prone Breast Irradiation for Pendulous Breasts [NA]
Clinical trial update for prone breast irradiation in pendulous breasts with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors [Phase 2]
Phase 2 trial evaluating low-dose tamoxifen citrate to reduce breast cancer risk in radiation-induced cancer survivors. Results were posted …
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial investigating letrozole in combination with imatinib mesylate for postmenopausal women with estrogen receptor–positiv…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates [Phase 1, Phase 2]
A neoadjuvant trial evaluating paclitaxel alone versus BIBF 1120 priming followed by BIBF 1120 plus paclitaxel in early HER-2 negative breas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating sapanisertib with exemestane or fulvestrant in postmenopausal ER+/HER2- metastatic breast cancer completed with pos…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer [Phase 1, Phase 2]
A phase 1/2 trial assessing pegylated liposomal doxorubicin plus albumin-bound paclitaxel and trastuzumab in HER-2 positive breast cancer is…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer. [Phase 2]
Phase 2 study evaluating neoadjuvant SHR6390 with anastrozole, pyrotinib, and trastuzumab in ER+/HER2+ breast cancer is in progress with unk…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for an experimental in-situ cancer vaccine across multiple solid tumors, including breast, colorectal, prostate, mela…
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients [Phase 3]
Phase 3 trial comparing TAC chemotherapy with or without zoledronic acid in HER2-negative breast cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study [Phase 2]
A Phase 2 pilot study evaluating nicotinic treatment for post-chemotherapy subjective cognitive impairment (often called chemo brain) has co…
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Quell Opioid Reduction and Pain Relief in Patients With Cancer [NA]
A terminated clinical trial update for Quell opioid reduction and pain relief in cancer patients, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Evaluating New Surgical Technique in Management of Female Patients With Operable Multifocal Breast Cancer [NA]
A clinical trial update evaluating a new surgical technique for operable multifocal breast cancer in female patients. Status and results are…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing 8 continuous vs 8 intermittent cycles in first/second line treatment for HER2-negative metastatic breast cancer has …
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer
A completed clinical trial evaluating predictive and prognostic tools to optimize frontline therapy with bevacizumab in HER2-negative aggres…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer [Phase 2]
Phase II study assessing neoadjuvant weekly paclitaxel and carboplatin followed by dose-dense epirubicin and cyclophosphamide in stage II-II…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Ketorolac in Breast Cancer Surgery [Phase 3]
Phase 3 clinical trial investigating ketorolac in breast cancer surgery has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer [Phase 2]
Phase 2 trial comparing oral CDB-4124 to placebo in stage I-II primary breast cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography [Phase 2]
Phase 2 clinical trial updating functional status of estrogen receptors in breast cancer using positron emission tomography; study completed…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Quantitative Subharmonic Breast Imaging [Phase 4]
Phase 4 clinical trial update for Quantitative Subharmonic Breast Imaging in breast cancer; results posted January 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy [Phase 2]
A Phase 2 trial evaluating propranolol in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy has completed wit…
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients [Phase 4]
Phase 4 trial comparing tapering low-dose dexamethasone to standard-of-care therapies for treatment-associated pain syndrome in early-stage …
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer [Phase 2]
A Phase 2 pilot study evaluating denosumab’s impact on disseminated tumor cells in patients with early-stage breast cancer; study terminated…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab [Phase 3]
A Phase 3 trial comparing paclitaxel plus bevacizumab to capecitabine plus bevacizumab in metastatic breast cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Mithramycin for Lung, Esophagus, and Other Chest Cancers [Phase 2]
Phase 2 trial of Mithramycin for lung, esophageal, and other chest cancers was terminated; results posted in 2019.